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Objectives. To compare the modiﬁed score for the assessment and quantiﬁcation of chronic rheumatoid aﬀections of the hands
(M-SACRAH) with the Australian/Canadian osteoarthritis hand index (AUSCAN) in hand osteoarthritis (HOA). Both are self-
administeredpatientquestionnaires,beingdesignedtoassessfunctionalstatus,stiﬀness,andpaininaﬀectedpatients,despitesome
diﬀerences in format, compass and arrangement of questions. Methods. 66 HOA patients (51 females), attending the outpatient
clinic, were included. Patients completed the AUSCAN (15 visual analogue scales) (VAS) and the M-SACRAH (12 VAS). Results.
AUSCAN-pain amounted to a mean of 41.9 (±2.9 SEM), AUSCAN-stiﬀness to 53.1 (3.7) and AUSCAN function to 42.6 (3.2).
M-SACRAH-function amounted to 25.4 (2.4), M-SACRAH-stiﬀness to 42.6 (3.0), and M-SACRAH-pain to 43.7 (3.1). The total
mean M-SACRAH was 37.2 (2.4) (all P’s <. 0001). The three respective domains of the two scores correlated signiﬁcantly: pain:
r = 0.73, stiﬀness: r = 0.75, and function: r = 0.76 (all P’s <. 0001). The four identical items in both scores also correlated
signiﬁcantly. No signiﬁcant gender speciﬁc diﬀerences were observed. Conclusion. Despite a diﬀerent scope of items, a signiﬁcant
highcorrelationofthesetwoscoresevaluatingHOApatientscouldbedemonstrated.Weconcludethatbothscoresareequivalently
valuable for the assessment of health status in these patients.
Copyright © 2009 Judith Sautner et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Hand osteoarthritis (HOA) is a highly prevalent condi-
tion, which can result in considerable disability. [1]I n
comparison with the diagnostic and therapeutic eﬀorts
concerning knee or hip OA, HOA was neglected for quite
some time—either due to its unspectacularity or due to
an u m b e ro fd i ﬃculties in its diagnosis and classiﬁcation.
Driven by European Standing Committee for International
Clinical Studies including Therapeutics (ESCISIT), separate
evidence-based recommendations for hip and knee OA were
developed between 2000 and 2005. In September 2005, the
members of the EULAR OA task force met for the ﬁrst
time to start developing recommendations primarily for the
management and afterwards for the diagnosis of HOA—thus
emphasizing the importance of this clinical topic [2, 3].
Already in 1999, the Osteoarthritis Research Society
International (OARSI) agreed upon core outcomes for
clinical trials in hand osteoarthritis (HOA) and these eﬀorts
have been renewed at the OARSI OA meeting in Boston
in December 2005 [4, 5] .T h e s er e s p e c t i v ec o r eo u t c o m e s
include pain, functional index, patient’s global assessment
(PGA), structure, number of painful or tender joints, grip
strength, and pinch strength. There was further agreement
that patients’ self-reported diﬃculty with daily activities
should be assessed with a valid and reliable measure [4].
Some eﬀorts to develop scoring systems for rheumatoid
aﬀectionsofthelittleﬁngerjointshavebeenmadeinthepast.
Two of them, the algofunctional index functional index for
hand osteoarthritis (FIHOA) by Dreiser and the rheumatoid
hand functional disability scale by Duruoz only assess the
functional handicap of patients [6, 7]. These two scores,2 International Journal of Rheumatology
furthermore, are administered by interviewers which might
result in bias due to interaction between the patient and the
interviewer [8].
We attempted to create a self-administered instrument
which did not only include a functional index but also
incorporated pain and stiﬀness and therefore designed the
score for the assessment and quantiﬁcation of chronic
rheumatic aﬀections of the hands, the SACRAH, in 1999 [9].
Bellamy et al. created a comparable score, following
the well-established pattern of the WOMAC and exclusively
dealing with HOA, the AUSCAN [8, 10, 11]. In this context,
it seems questionable, whether an instrument is capable of
targeting HOA exclusively.
As both AUSCAN and M-SACRAH meet the require-
ments of the OARSI hand osteoarthritis core outcomes, yet
have been designed by diﬀerent approaches, we compared
both scores in one HOA patient group to verify possible
diﬀerences or similarities in the assessment of the status
and outcomes of these patients. Special emphasis of our
investigation was put on possible diﬀerences between the
two scores concerning their results in diﬀerent genders. A
further goal was to investigate possible diﬀerences in the
responsivenessofthetwoscorestotherapeuticinterventions.
2.MaterialandMethods
Between August 2003 and April 2005, the four authors
were assessing patients at the outpatient clinic of our
department. Having been diagnosed with HOA according to
the ACR criteria by one of the four, patients were included
consecutively into the study [12]. Thus, sixty six outpatients
completed both questionnaires.
2.1. Questionnaires under Comparison
2.1.1. SACRAH/M-SACRAH. In brief, the SACRAH encom-
passes 23 VAS (100mm) covering the three categories
functional impairment (18 items), stiﬀness (2 items), and
pain (4 items). This score has been validated in 69 HOA and
103 RA patients [13].
In 2004, we presented a modiﬁed and shortened version
of the SACRAH, the M-SACRAH to simplify the question-
naire’s use for the patient [14].
The M-SACRAH—as well as its predecessor, the
SACRAH—has been established and validated in German
and also consists of 3 domains including 12 items, namely, 8
targeting function, 2 targeting stiﬀness, and 2 targeting pain.
It has, meanwhile, been translated to English according to
standardized procedures. Meanwhile, the questionnaire has
been translated to English and Serbocroatian according to
standardized procedures and has been validated in a Serbian
patient group [15]. Data of the principal component analysis
are given in Table 6.
2.1.2. AUSCAN-Questionnaire. The AUSCAN has been
established in English, exclusively dealing with HOA patients
and ﬁnally published in 2002. It exists in a Likert version,
a numerical rating scale (NRS), and in a VAS format
Table 1: Items and results of the AUSCAN. (Identical questions in
both questionnaires are given in italics.)
Domain question mean (SEM)
Pain
Pain at rest 35.8 (3.4)
Pain at gripping 45.7 (3.8)
Pain at lifting 46.3 (3.6)
Pain at turning 45.2 (3.8)
Pain at squeezing 36.7 (3.6)
Stiﬀness
Morning stiﬀness 53.2 (3.7)
Physical function
Turning taps/faucets on 30.1 (3.3)
Turning doorknob/handle 24.8 (3.1)
Doing up buttons 35.0 (3.7)
Fastening jewellery 47.4 (4.2)
Opening a new jar 57.0 (4.1)
Carrying full put one hand 47.8 (4.1)
Peeling vegetables/fruit 37.4 (3.7)
Picking up large heavy objects 47.8 (4.1)
Wringing out washcloths 53.9 (4.1)
Table 2: Items and results of the M-SACRAH. (Identical questions
in both questionnaires are given in italics.)
Domain question mean (SEM)
Function
Locking/unlocking of a door 21.9 (2.6)
Buttoning and unbuttoning shirt/blouse 31.1 (3.2)
Turning the water tap 28.1 (3.1)
Fastening or unfastening a zip 24.1 (3.0)
Tying shoelaces 28.4 (3.3)
Unscrewing cap of a tube of toothpaste 26.7 (2.9)
Turning the pages of a newspaper 18.9 (2.3)
Writing 24.0 (2.8)
Stiﬀness
Morning stiﬀness 53.8 (3.6)
Stiﬀness later in the day following inactivity 31.3 (3.1)
Pain
Pain during intensive work 47.7 (3.6)
Pain at times of inactivity 39.6 (3.5)
[8, 10, 11]. It comprises 15 items covering pain (n = 5),
stiﬀness (n = 1), and function (n = 9). The distribution of
questions among the three categories, however, is to some
extent diﬀerent from the M-SACRAH.
For the purpose of this study, the VAS-version was used,
as the M-SACRAH also encompasses VAS-scales. As the
AUSCAN questionnaire is not in the public domain and thus
not unrestrictedly available, the candidate items from the
publication were used to generate a German version for this
speciﬁc study. This was done by two professional English-
German translaters, one translating the questionnnaire fromInternational Journal of Rheumatology 3
Table 3: Gender diﬀerences of the single domains.
Female patients Male patients P-values
AUSCAN pain 41.1 (3.3) 45.9 (6.4) .54
MSACRAH pain 43.3 (3.5) 45.6 (5.4) .77
AUSCAN stiﬀness 52.8 (4.1) 54.4 (8.6) .87
MSACRAH stiﬀness 42.4 (3.4) 43.2 (6.6) .92
AUSCAN function 43.2 (3.6) 39.4 (6.9) .65
MSACRAH function 24.2 (2.5) 30.9 (6.6) .28
Table 4: Mean diﬀerence (SEM = standard error of the mean) of domain scores before and after NSAID change due to ineﬃcacy.
Pre-NSAID change Post-NSAID change P-values
AUSCAN pain 52.7 (8.9) 41.9 (7.2) .16
MSACRAH pain 51.1 (9.5) 41.7 (6.4) .23
AUSCAN stiﬀness 57.8 (9.6) 45.5 (8.3) .19
MSACRAH stiﬀness 49.0 (6.6) 36.5 (6.8) .57
AUSCAN function 42.2 (10.2) 44.9 (7.4) .84
MSACRAH function 27.2 (6.9) 1.3 (5.7) .52
English into German, the other one translating it back into
English. Since the English translation from the German
version matched the original AUSCAN questionnaire, the
German version was considered primarily valid for the use
in this study. The detailed items of the questionnaire are
shown in Table 1. Construct validity of this German version
was assessed carrying out principal component analysis
(Table 7).
The main diﬀerence between the two questionnaires
relates to the importance of stiﬀness and pain. While the
AUSCAN distinguishes between pain on several activities,
the M-SACRAH asks for pain at work in general and for pain
at rest. Regarding stiﬀness only morning stiﬀness is covered
by the AUSCAN. The M-SACRAH, however, also asks for
starting stiﬀness during the day.
2.1.3. Completion of the Questionnaires and Further Assess-
ments. After initial instruction by a nurse or a resident, as
to how the questionnaires should be tackled, the participants
completed both forms without further assistance in random
order, one right after arrival and the other one just before
the assessment by the physician, resulting in a mean time
lag of half an hour. All questionnaires were completed
during outpatient department hours between 9 a.m. and 1
p.m. Patients thereafter underwent a clinical examination
with an assessment of their complete joint status, also
including patient’s global assessment (PGA)and physician’s
global assessment (PhGA) (100mm VAS).
PGA was assessed by the treating physician, using the
phrase “Please indicate how severe you are compromised by
your hand osteoarthritis during the last 48 hours!”
2.2. Statistical Methods. Statistical evaluation was carried
out using SPSS 11.0 for Windows. As all the relevant
parameters proved to be normally distributed according to
Kolmogorov-Smirnoﬀ accomodation, parametric tests were
applied. Results are presented as mean (± standard error
of the mean = SEM) for continuous variables. Correlations
of continuous variables were performed using Pearson’s
correlation. Groups were compared using the Student’s t-
test. P-values <.05 were considered statistically signiﬁcant.
In order to evalutate dimensionality and factorial struc-
ture of both scores, and to reveal whether scale items
eventually cross-load on more than one factor, exploratory
factor analysis by principial component analysis (PCA) was
performed (Tables 5 and 6).
Factor analysis, including variations such as PCA, is a
statistical approach which is applied to analyze interrelation-
ships among a large number of variables and to explain these
variables with respect to their common underlying dimen-
sions (factors). The objective is the attempt to condense
information contained in a number of original variables into
a smaller set of variates (factors) with a minimum loss of
information [16]. Moreover, reliability as a measure of the
extent to which a variable or a set of variables is consistent in
what it is intended to measure was assessed by calculating
Cronbach’s alpha. The closer the value comes to one, the
stronger the connection between the diﬀerent variables is
assumed. Values greater than 0.7 are generally regarded as
markers of high reliability.
3. Results
Of the enrolled 66 patients, 51 (77%) were female, 15
(23%) male, their mean age was 58.3 (45–83) years, with
a mean disease duration of 40 (3–365) months. For the
radiological assessment, the Kellgren Lawrence classiﬁcation
was applied. Four patients (6%) were Kellgren Lawrence
stadium I, 16 (24%) in stadium II, 31 (47%) stadium III,
and the remaining 15 patients (23%) in stadium IV. Patients4 International Journal of Rheumatology
Table 5: Correlations of single domains and total M-SACRAH with PGA/PhGA.
PGA PhGA
AUSCAN pain r = 0.59 (P<. 0001) r = 0.56 (P<. 0001)
M-SACRAH pain r = 0.56 (P<. 0001) r = 0.50 (P < .0002)
AUSCAN stiﬀness r = 0.49 (P < .0003) r = 0.37 (P < .0059)
M-SACRAH stiﬀness r = 0.53 (P<. 0001) r = 0.45 (P < .0007)
AUSCAN function r = 0.55 (P<. 0001) r = 0.40 (P < .0025)
M-SACRAH function r = 0.55 (P<. 0001) r = 0.46 (P < .0005)
M-SACRAH total r = 0.65 (P<. 0001) r = 0.54 (P<. 0001)
Table 6: Principal component analysis of the M-SACRAH items.
Rotated component matrix (item loading).
Question Component 1 Component 2 Component 3
M-SACRAH 1 0.53 0.003 0.949
M-SACRAH 2 0.602 0.511 0.41
M-SACRAH 3 0.687 0.328 0.237
M-SACRAH 4 0.785 0.246 0.002
M-SACRAH 5 0.648 0.364 0.031
M-SACRAH 6 0.686 0.383 0.328
M-SACRAH 7 0.845 −0.048 −0.022
M-SACRAH 8 0.765 −0.016 −0.024
M-SACRAH 9 0.186 0.808 0.051
M-SACRAH 10 0.201 0.790 −0.061
M-SACRAH 11 0.496 0.587 0.134
M-SACRAH 12 −0.20 0.888 0.044
Extraction method: principal component analysis.
Rotation method: varimax with Kaiser normalization.
The backgroud indicates questions loading on the same factor.
with isolated thumb base osteoarthritis were not included
into the study. Considering gender distribution, disease
duration, and radiological status, the patient group can be
regarded representative for the overall HOA patients being
treated at our clinic. All patients were current users of either
paracetamol or NSAIDs. In eleven NSAID-treated patients,
the currently used drug was changed because of ineﬃcacy
at the time of their ﬁrst assessment and subjects were
reassessed after a mean of 39 (±4 SEM) days. All patients
were Caucasian and their mother tongue was German. All
of them gave written informed consent to be enrolled into
the study according to the declaration of Helsinki. The
design of the study has been approved by the local ethics
committee.
The majority of sixty two patients (94%) properly com-
pleted both questionnaires without missing data. Four of the
ﬁfteen male patients (27%) completed M-SACRAH without
any problems but had incomplete AUSCAN questionnaires
(e.g., they did not ﬁll in all physical function questions
asserting never to perform these activities, i.e., closing
bracelets) and were therefore excluded from further analysis.
AUSCAN pain amounted to 41.9 (±2.9 SEM), AUSCAN
stiﬀness to 53.1 (3.7), and AUSCAN function to 42.6 (3.2).
M-SACRAH-function amounted to a mean of 25.4 (2.4),
M-SACRAH-stiﬀness to 42.6 (3.0), and M-SACRAH-pain to
43.7 (3.1). The mean total M-SACRAH was 37.2 (2.4).
The single domains of the two scores correlated signif-
icantly pain: r = 0.73 (P<. 0001), stiﬀness r = 0.75 (P<
.0001), and function r = 0.76 (P < 0.0001).
The four items which are identical in both scores also
correlated signiﬁcantly: r = 0.88 (P<. 0001) for “pain at
rest,” r = 0.78 (P<. 0001) for “morning stiﬀness,” r = 0.75
(P<. 0001) for “turning taps,” and r = 0.80 (P<. 0001) for
“doing up buttons.”
Gender-speciﬁc results for the AUSCAN and M-
SACRAH did not diﬀer signiﬁcantly. However, it seems note-
worthy that for all domains except the AUSCAN function a
trend to higher values was seen in male patients, see Table 3.
Changes of both scores following a therapeutic change,
for example, from an ineﬀective NSAID to another one, were
notstatisticallysigniﬁcantlydiﬀerent,however,therespective
changes of the mean values were well comparable for both
items, see Table 4.
Mean PGA amounted to 39 (±3 SEM), mean PhGA to 23
(2). Correlations between PGA and the single domains of the
AUSCAN and M-SACRAH as well as the total M-SACRAH
reached statistical signiﬁcance. The same, PhGA and the
single domains of either instrument correlated signiﬁcantly.
The best correlation, however, could be demonstrated for
the total M-SACRAH and PGA (r = 0.65; P<. 0001), see
Table 5.
Reliability testing of both scores was carried out by
Cronbach’s alpha, which amounted to 0.916 for the total M-
SACRAHandto0.952forthetotalAUSCAN,indicatinghigh
internal consistency.
Thecompleteresultsofexploratoryfactoranalysisforthe
M-SACRAH items and AUSCAN items are given in Tables
6 and 7. This statistical procedure revealed both aggregate
scores to be three dimensional, while the respective single-
domain scores were found to be strictly one dimensional, see
also the backgrounds within the respective tables.
4. Discussion
M-SACRAH and AUSCAN, two self-administered patient
centered questionnaires, were compared in a group of HOA
patients. We were able to show an equal ability of either
instrument to describe physical function, pain, and stiﬀness
in this speciﬁc patient group.International Journal of Rheumatology 5
Table 7: Principal component analysis of the AUSCAN items.
Rotated component matrix (item loading).
Question Component 1 Component 2 Component 3
AUSCAN 1 −0.35 −0.006 −0.776
AUSCAN 2 0.169 0.902 0.159
AUSCAN 3 0.539 0.626 0.149
AUSCAN 4 0.580 0.598 −0.099
AUSCAN 5 0.259 0.744 −0.297
AUSCAN 6 0.539 0.442 0.120
AUSCAN 7 0.551 0.455 0.362
AUSCAN 8 0.898 0.109 −0.184
AUSCAN 9 0.833 0.286 0.297
AUSCAN 10 0.740 0.462 0.329
AUSCAN 11 0.675 0.499 0.309
AUSCAN 12 0.360 0.712 0.396
AUSCAN 13 0.815 0.327 −0.039
AUSCAN 14 0.439 0.699 0.059
AUSCAN 15 0.760 0.490 0.141
Extraction Method: principal component analysis.
Rotation Method: varimax with Kaiser normalization.
The background indicates questions loading on the same factor.
To facilitate an objective follow-up of patients suﬀering
from HOA, the application of appropriate aggregate scores
to describe the patient’s status has been considered desirable
aside the assessment of pain and functioning [5, 17].
The M-SACRAH was developed from its more complex
predecessor, the SACRAH, which was constructed using a
Delphi approach including rheumatologists and occupa-
tional therapists [13, 14]. The modiﬁed score reduced item
set was reached by excluding all items of the SACRAH, which
correlated with a coeﬃcient of equal or more than 0.7. The
AUSCAN in contrast was developed by ﬁrst collecting a large
number of items through interviews with 50 HOA patients.
This item pool was rationalized according to prevalence,
frequency, and importance to the patient. Subsequently, 15
“candidate” items were selected for the questionnaire. A
second group of 24 “reserve” items was kept for addressing a
methodologicalissuerelatingearlyversuslateitemreduction
in index construction, which has not been published yet
[8, 11].
As the AUSCAN is not unrestrictedly available, even for
scientiﬁc purposes, a linguistic validation procedure of these
items had to be performed. However, if a questionnaire is
translated into another language, a linguistic validation is
necessary but not suﬃcient unless the psychometric charac-
teristicshavebeenveriﬁed.Thus,thefollowingpsychometric
evaluation can also be regarded as a proof of this instrument
validity [18].
Both scores encompass a comparable number of ques-
tions but put a diﬀerent emphasis on the investigated
domains function, stiﬀness, and pain due to their devel-
opment process. We, therefore, decided to investigate as to
whether these diﬀerences would take eﬀect on the results of
the scores.
The absolute values indeed signiﬁcantly diﬀered with
respecttothefunctionandstiﬀnessdomains.Thediﬀerences
in the function domain can be seen due to the diﬀerent
scope of questions addressing functions requiring physical
force like holding a pan or wringing out washcloths that
are highlyer represented within the AUSCAN questionnaire.
Regarding stiﬀness, the results of the M-SACRAH were
lower than those of the AUSCAN obviously due to the
p r e s e n c eo fas e c o n di t e m“ s t i ﬀness later in the day following
inactivity” which yields signiﬁcantly lower results than the
item “morning stiﬀness” shared by both scores. Absolute
values for pain in contrast to the two other domains did
not diﬀer as the items “pain at gripping,” “at lifting” and
“at turning” of the AUSCAN obviously relate to “pain during
hard work” of the M-SACRAH.
Despite these diﬀerences regarding absolute values, how-
ever, an expected consistently high correlation between the
threedomainsofbothinstrumentscouldbefoundindicating
thatbothscoresdescribetheinvestigatedcohortequallywell.
Internalconsistency,asassessedbyCronbach’salpha,was
found excellent for both the AUSCAN as well as the M-
SACRAH, which indeed is caused by the high number of
items. As alpha can also be regarded as a measure of redun-
dancy, the small diﬀerences between both scores are based
on the greater number of items included into the AUSCAN,
as commonly reliability coeﬃcients of compositive indices
increase by an increasing number of single components [16].
The consistently high correlation between the single
items of both instruments can be regarded a strong marker
for convergent validity.
Discriminant validity has been tested in the SACRAH,
healthy controls serving as comparative group [13]. Address-
ingthistopic,recentdatahaverevealedsigniﬁcantdiﬀerences
of the SACRAH as well as the M-SACRAH in HOA and RA
patients [15]. Detailed data on validity and factor structure
of the AUSCAN have been published in 2006 [19, 20].
Despite no signiﬁcant diﬀerence between female and
male patients’ results, a predominance of items addressing
household activities in the AUSCAN was obvious. Concord-
ingly, we observed a considerable number of male patients
(27%) who did not complete one or more questions of the
function domain of the AUSCAN, some of them adding a
written commentary that they would never perform such
work. Although the investigated number of male patients is
small, a considerable part of those considered the scope of
the AUSCAN’s items as not fully suitable describing their
diﬃculties in daily life. Thus, a detailed investigation of
this subject seems to be appropriate as, in addition, male
patients tended to score higher in the AUSCAN as well as
in the M-SACRAH. Following a change of NSAID due to
ineﬃcacy, neither the AUSCAN nor the M-SACRAH showed
signiﬁcant changes, obviously due to the small number of
patients. Nevertheless, changes in the three domains of the
two instruments were of the same magnitude and toward
the same direction. The responsiveness to therapy has been
shown for the AUSCAN and the SACRAH in previous
publications [5, 13].
The correlations of both scores with PGA underline
either ability to express the patient’s present situation.
Among those, the strongest correlation could be found for
PGA and the total M-SACRAH, which can be regarded an6 International Journal of Rheumatology
advantage of this “total” aggregate score. PhGA did not
correlate that strongly with both instruments. This can be
seen in line with our ﬁndings about the diﬀerent view
of physicians and patients concerning their present disease
activity as well as the respective changes in RA patients [21].
An important aspect of this study was to test the
construct validity of both scores, which was done by
principal component analysis. Both scores, when analyzed
as an aggregate, appeared to be tridimensional instruments,
reﬂecting the three domains covered by the scores. Although
no composite AUSCAN value was proposed, it would be
statistically justiﬁed to give [8]. As it is the case for the M-
SACRAH, an aggregate result of the AUSCAN is supposed to
measure the severity of the underlying disease [14].
As expected, this statistical approach revealed a con-
siderable number of redundant questions. Thus, it would
be possible to reduce the number of items of both scores
signiﬁcantly according to these results. A possible future
perspective would be the validation of a short form (SF-)
SACRAH or AUSCAN in order to facilitate the application
of these instruments in daily routine [22].
Recent studies on the measurement of functioning in
HOA patients have compared several questionnaires (HAQ,
AUSCAN, Cochin scale, FIHOA, SACRAH, and AIMS2-SF)
based on the International Classiﬁcation of Functioning,
Disability, and Health (ICF) [23]. Among those, SACRAH
and AUSCAN showed the lowest diversity ratio, in con-
trast, AIMS2-SF the highest. The authors conclude that
clinicians, when selecting an instrument for comprehensive
measurementoffunctioning,areadvisedtoincludebothone
instrument with a low diversity ratio (for disease speciﬁc
aspects) and another instrument with a high diversity ratio
(for broader aspects of functioning including some aspects
of participation).
Hand osteoarthritis and its speciﬁc assessment and
treatment have received less attention than hip and knee OA
in the past. Recent eﬀorts to this entity mirror an increasing
scientiﬁc interest in HOA, ending up with the creation and
application of patient-centered outcome measures [2, 3].
Future research on HOA is expected to focus on good
longitudinal studies and improved interventions.
In summary, apart from the observed diﬀerences in
absolute values, both instruments can be regarded equally
well able to describe physical function, pain, and stiﬀness of
patients suﬀering from HOA. They may, therefore, both be
considered equally suitable as core items in the evaluation of
these patients.
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